BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1319602)

  • 1. Benzodiazepine receptor mediation of behavioral effects of nitrous oxide in mice.
    Quock RM; Emmanouil DE; Vaughn LK; Pruhs RJ
    Psychopharmacology (Berl); 1992; 107(2-3):310-4. PubMed ID: 1319602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors.
    Emmanouil DE; Johnson CH; Quock RM
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):167-72. PubMed ID: 7862891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine receptor-mediated behavioral effects of nitrous oxide in the rat social interaction test.
    Quock RM; Wetzel PJ; Maillefer RH; Hodges BL; Curtis BA; Czech DA
    Pharmacol Biochem Behav; 1993 Sep; 46(1):161-5. PubMed ID: 8255907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker.
    Czech DA; Quock RM
    Psychopharmacology (Berl); 1993; 113(2):211-6. PubMed ID: 7855183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm.
    Milman A; Weizman R; Rigai T; Rice KC; Pick CG
    Behav Brain Res; 2006 Jun; 170(1):141-7. PubMed ID: 16574254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of agents active at the gamma-aminobutyric acid receptor complex in the staircase paradigm.
    Weizman R; Paz L; Peter Y; Toren P; Pick CG
    Brain Res; 2001 May; 901(1-2):137-42. PubMed ID: 11368960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test.
    Li S; Quock RM
    Pharmacol Biochem Behav; 2001 Apr; 68(4):789-96. PubMed ID: 11526978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between nitrous oxide and diazepam in the mouse staircase test.
    Pruhs RJ; Quock RM
    Anesth Analg; 1989 Apr; 68(4):501-5. PubMed ID: 2564750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of benzodiazepine antagonists in chlordiazepoxide tolerant and non-tolerant rats.
    Takada K; Suzuki T; Hagen T; Cook JM; Katz JL
    Life Sci; 1989; 44(4):289-99. PubMed ID: 2492629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral studies with anxiolytic drugs. I. Interactions of the benzodiazepine antagonist Ro 15-1788 with chlordiazepoxide, pentobarbital and ethanol.
    Barrett JE; Brady LS; Witkin JM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):554-9. PubMed ID: 2989486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate decreases exploratory behaviour in mice: development of tolerance and cross-tolerance with chlordiazepoxide.
    File SE; Aranko K
    Eur J Pharmacol; 1988 Jul; 151(2):293-9. PubMed ID: 2844555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of nitrous oxide analgesia by benzodiazepine receptors.
    Emmanouil DE; Quock RM
    Anesth Prog; 1989; 36(1):5-8. PubMed ID: 2604055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations.
    Miller LG; Galpern WR; Greenblatt DJ; Lumpkin M; Shader RI
    J Pharmacol Exp Ther; 1990 Jul; 254(1):33-8. PubMed ID: 2164100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nitrous oxide, morphine and diazepam effects in the mouse staircase test.
    Quock RM; Wojcechowskyj JA; Emmanouil DE
    Psychopharmacology (Berl); 1987; 92(3):324-6. PubMed ID: 3114784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors.
    Quock RM; Best JA; Chen DC; Vaughn LK; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1990 Jan; 175(1):97-100. PubMed ID: 2157601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine receptor ligands and sexual behavior in the male rat: the role of GABAergic mechanisms.
    Agmo A; Fernández H
    Pharmacol Biochem Behav; 1991 Apr; 38(4):781-8. PubMed ID: 1651517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to the behavioral effects of chlordiazepoxide: pharmacological and biochemical selectivity.
    Sannerud CA; Marley RJ; Serdikoff SL; Alastra AJ; Cohen C; Goldberg SR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1311-20. PubMed ID: 8263795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlordiazepoxide alters intravenous cocaine self-administration in rats.
    Goeders NE; McNulty MA; Mirkis S; McAllister KH
    Pharmacol Biochem Behav; 1989 Aug; 33(4):859-66. PubMed ID: 2559416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of microwave exposure on chlordiazepoxide effects in the mouse staircase test.
    Quock RM; Klauenberg BJ; Hurt WD; Merritt JH
    Pharmacol Biochem Behav; 1994 Apr; 47(4):845-9. PubMed ID: 8029254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.